4//SEC Filing
SIEGAL JONATHAN 4
Accession 0001140361-25-006081
CIK 0000887359other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 4:05 PM ET
Size
10.6 KB
Accession
0001140361-25-006081
Insider Transaction Report
Form 4
Vericel CorpVCEL
SIEGAL JONATHAN
Principal Accounting Officer
Transactions
- Sale
Common Stock
2025-02-25$52.07/sh−1,137$59,204→ 1,206 total - Exercise/Conversion
Common Stock
2025-02-24+1,875→ 3,081 total - Tax Payment
Common Stock
2025-02-24$52.33/sh−738$38,620→ 2,343 total - Exercise/Conversion
Restricted Stock Unit
2025-02-24+1,875→ 5,625 total→ Common Stock (1,875 underlying)
Footnotes (7)
- [F1]The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 22, 2024. The remaining RSUs will vest in annual installments on February 22, 2026, February 22, 2027, and February 22, 2028, respectively.
- [F2]These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F3]These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.
- [F4]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.
- [F5]Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
- [F6]No expiration date for this type of award.
- [F7]The Fair Market Value of the vested derivative securities is $52.33 per share.
Documents
Issuer
Vericel Corp
CIK 0000887359
Entity typeother
Related Parties
1- filerCIK 0001916145
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 4:05 PM ET
- Size
- 10.6 KB